This review is aimed to provide a concise yet extensive survey of key short bioactive peptide
sequences for a range of applications ranging from biomaterials development to peptides …

The selective infiltration of cell membranes and tissue barriers often blocks the entry of most
active molecules. This natural defense mechanism prevents the invasion of exogenous …

Cell-penetrating peptides (CPP) are promising tools for the transport of a broad range of
compounds into cells. Since the discovery of the first members of this peptide family, many …

The blood–brain barrier (BBB) hampers the delivery of therapeutic proteins into the brain.
BBB-shuttle peptides have been conjugated to therapeutic payloads to increase the …

Novel stroke therapies are needed. Inhibition of the interaction between the postsynaptic
density-95 (PSD-95)/disc large/ZO-1 (PDZ) domains of PSD-95 and the N-methyl-D …

Aim: To develop novel peptide-based nanocomplexes (NCs) for delivery of anti-miRNA
oligonucleotides to human-derived pancreatic stellate cells (hPSCs), precursors of cancer …

Hypothesis The distribution of three cell-penetrating peptides (CPPs) with different
architectures (short, long linear and branched) on poly (lactic-co-glycolic) acid (PLGA) …

Bioactive low-molecular-weight compounds are actively pursued, as an alternative to
macromolecules, for biomedical applications such as drug and gene delivery. However …

Cell-penetrating peptides (CPPs) are known to interact with cell membranes and by doing
so enhance cellular interaction and subsequent cellular internalization of nanoparticles. Yet …

Multivalent cell-penetrating peptides (CPPs) have been reported to show enhancement in
cellular uptake and endosomolytic activity. However, its application was limited to trans …